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Photoactivation of ROS Production In Situ Transiently
Activates Cell Proliferation in Mouse Skin and in the
Hair Follicle Stem Cell Niche Promoting Hair Growth
and Wound Healing
Elisa Carrasco1,2,3,6, María I. Calvo1,2,6, Alfonso Blázquez-Castro1,2,7, Daniela Vecchio3,4, Alicia Zamarrón2,
Irma Joyce Dias de Almeida1,2, Juan C. Stockert2, Michael R. Hamblin3,4,5, Ángeles Juarranz2 and
Jesús Espada1,2,6
The role of reactive oxygen species (ROS) in the regulation of hair follicle (HF) cycle and skin homeostasis is
poorly characterized. ROS have been traditionally linked to human disease and aging, but recent ﬁndings
suggest that they can also have beneﬁcial physiological functions in vivo in mammals. To test this hypothesis, we
transiently switched on in situ ROS production in mouse skin. This process activated cell proliferation in the
tissue and, interestingly, in the bulge region of the HF, a major reservoir of epidermal stem cells, promoting hair
growth, as well as stimulating tissue repair after severe burn injury. We further show that these effects were
associated with a transient Src kinase phosphorylation at Tyr416 and with a strong transcriptional activation of the
prolactin family 2 subfamily c of growth factors. Our results point to potentially relevant modes of skin
homeostasis regulation and demonstrate that a local and transient ROS production can regulate stem cell and
tissue function in the whole organism.
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INTRODUCTION
The skin is the largest organ in mammals, consisting of three
layers, epidermis, dermis, and hypodermis, with associated
appendages, including hair follicles (HFs), sebaceous, and
sweat glands. The biology of epidermal stem cells in the skin
is well known (Blanpain and Fuchs, 2009; Baker and Murray,
2012). In particular, the pilo-sebaceous unit (HF and
associated glands) and the HF growth cycle constitute a very
well-characterized model to study the functional regulation of
skin stem cells. The HF is a complex mini-organ that
invaginates from epidermal sheets of the skin into the dermis
(Muller-Rover et al., 2001; Baker and Murray, 2012; Gilhar
et al., 2012). Hair production is the result of a cyclic activity of
the HF alternating three sequential phases: anagen (growth),
catagen (cessation and regression), and telogen (rest). The HF
is divided into two main regions depending on size variation
rates through the hair cycle: permanent and cyclic regions.
The upper permanent region, composed of the infundibulum,
associated glands, and the bulge, a major reservoir of HF stem
cells, regulates the activity of the dermal papilla in the cyclic
region (Ramos et al., 2013). Activation of the dermal papilla
cells during the anagen phase promotes extensive cell
proliferation and differentiation in the cyclic region,
ultimately resulting in the formation and growth of the hair
shaft. Skin components are constantly renewed by a stock of
multipotent epidermal stem cells, which are located in the
bulge region (Bg) of the HF and in the basal layer of the
interfollicular epithelium (Blanpain and Fuchs, 2009; Baker
and Murray, 2012).
Important and well-known molecular mechanisms, includ-
ing Wnt/β-catenin, BMP/Tgfβ/Smad, PI3K/Akt, and ERK/MAPK
signaling pathways (Baker and Murray, 2012; Lopez-Pajares
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et al., 2013; Ramos et al., 2013), have key roles in the
regulation of different aspects of skin stem cell and HF
function. However, skin homeostasis and the HF cycle are
extremely complex and multifactorial processes. Many of the
interplaying mechanisms that govern and/or modulate the
functional output of these processes are not well
characterized. In particular, the potential physiological role
of reactive oxygen species (ROS) in the skin is largely
unknown.
The generation of ROS as by-products of essential and
efﬁcient metabolic reactions, such as cellular respiration or
oxidase activity, is an inevitable biochemical side effect that
can be extremely harmful for cell viability. The oxidative
stress induced by the undesirable intracellular accumulation
of ROS is a major cause of cell and tissue toxicity, and it is
associated with several human diseases, including neurode-
generative (Parkinson’s, Alzheimer’s, and Huntington’s dis-
eases), psychiatric (schizophrenia and bipolar disorder) and
cardiovascular (stroke and myocardial infarction) disorders
(Pieczenik and Neustadt, 2007; Valko et al., 2007). ROS are
also implicated in sickle cell disease and the fragile X and
chronic fatigue syndromes (el Bekay et al., 2007; Pieczenik
and Neustadt, 2007). The so-called oxidative stress or free-
radical theory of aging proposes a causal link between
gradual, time-dependent ROS production during the whole
lifetime and aging of the organism, a controversial theory that
remains the subject of intense debate (Perez et al., 2009;
Speakman and Selman, 2011).
Aerobic organisms have evolved powerful mechanisms to
manage excess ROS production, and they are able to
efﬁciently detoxify superoxide anions, hydroxyl radicals,
hydrogen peroxide, and organic hydroperoxides into harm-
less H2O and O2. These mechanisms are exempliﬁed by the
superoxide dismutase, catalase, and glutathione peroxidase
enzymatic systems (Machlin and Bendich, 1987; Fernandez
and Videla, 1996; Mates and Sanchez-Jimenez, 1999).
Interestingly, in the course of evolution, eukaryotic
organisms have also developed systems to use ROS
production for their own beneﬁt. An example is the
phagocyte, which is an essential cell player of the
mammalian immune system that can produce radical
oxygen and nitrogen species in a tightly controlled way to
kill target pathogens (Klebanoff et al., 1983; Bylund et al.,
2010).
Accumulated evidence suggests that eukaryotic cells can
also actively promote the production of small amounts of ROS
as part of signaling pathways that regulate cell survival and
proliferation (Droge, 2002; Chiarugi and Cirri, 2003; Bartosz,
2009; Sena and Chandel, 2012). Furthermore, it has been
reported that exogenous ROS can regulate stem cell function
in in vitro systems (Le Belle et al., 2010). An abnormal ROS
production has been also linked to the deregulation of
intestinal stem cell proliferation that occurs during
colorectal cancer initiation (Myant et al., 2013). These
observations imply the existence of widespread ROS-
dependent mechanisms for the regulation of cell function
and tissue homeostasis. Here we have used the skin and the
well-characterized epidermal stem cell niche located in the
Bg of the mouse HF as a working model to provide a proof-of-
concept for the hypothesis that a transient modulation of
in situ ROS levels can regulate skin homeostasis and stem cell
function in a whole organism.
RESULTS
Photodynamic treatment of mouse skin with methyl
aminolevulinate and red light induces a transient in situ ROS
production in the tissue
To this end, we ﬁrst developed a reproducible method to
promote a controlled and transient increase of ROS in the
skin. High levels of intracellular ROS can be generated by a
combination of light of an adequate wavelength and a
photosensitizer (PS) in the presence of O2 (Juarranz et al.,
2008). The resulting photodynamic effect (Supplementary
Figure S1A online) is widely used as a powerful cell killing
method in clinical practice (photodynamic therapy) for the
treatment of several skin diseases, including cancer and
infections. At present, 5-aminolevulinic acid (ALA) or its
methyl derivative (methyl aminolevulinate; mALA) in combi-
nation with red light is the most widely used photodynamic
therapy in the clinic. These compounds are not PS per se, but
they function as precursors of the endogenous PS Proto-
porphyrin IX (PpIX; Supplementary Figure S1B online;
Juarranz et al., 2008).
We have previously demonstrated that mALA can be used
to photogenerate tightly controlled low levels of intracellular
ROS that are able to stimulate cell proliferation instead of cell
death in cultured immortalized keratinocytes (Blazquez-
Castro et al., 2012). Here, we have adapted this approach
to mouse skin in vivo. We have evaluated irradiation doses
from 2 to 10 J cm−2 and a ﬁxed mALA concentration (25 mg
Metvix, mALA 160mg g− 1 cream). We found that topical
application of mALA on mouse dorsal skin promoted an
extensive production and accumulation of PpIX in the tissue,
as revealed by the characteristic reddish ﬂuorescence of this
compound under blue-light (407 nm) excitation (Figure 1a).
As expected, mALA-dependent PpIX accumulation in the skin
followed by 2.5 J cm− 2 irradiation with red light (636 nm) to
complete the photodynamic treatment (mALA+Light) resulted
in a signiﬁcant increase of in situ ROS levels in the tissue
(Figure 1b). A time-course analysis showed that relative ROS
production was transient, returning to initial levels 100 min-
utes after irradiation (Figure 1b). To gain further detail on the
distribution of generated ROS in the tissue, we used the
manageable mouse tail skin epithelium. Accordingly, experi-
mental treatments and the localization of PpIX and ROS were
evaluated ex vivo in whole pieces of the tissue. We
established that incubation with mALA resulted in a
signiﬁcant accumulation of PpIX in the HF (Figure 1c),
followed by a notable production of ROS after 10 J cm− 2 of
red-light irradiation (mALA+Light) that was detected to some
degree all over the epidermis, including IFE, infundibulum,
and sebaceous glands (Figure 1d). Notably, ROS signal
rapidly disappeared or declined in most tissue locations,
persisting for longer times in bulge cells (Figure 1d), which is
the main niche or reservoir of epidermal stem cells in the skin.
As these experiments were performed ex vivo to determine
E Carrasco et al.
In Vivo Stem Cell Activation by ROS
2612 Journal of Investigative Dermatology (2015), Volume 135
ROS localization, the time course of ROS production is not
comparable to that observed in vivo in back skin. However,
these results corroborate the transient nature of ROS produc-
tion in the skin induced by our experimental approach, as
well as the remarkable incidence on the bulge stem
cell niche.
To rule out the deleterious effects of our protocol on cell
and tissue viability, we used different approaches. We
analyzed the formation of phosphorylated histone H2AX
(pH2AX; also known as gammaH2AX) foci on the chromatin
ﬁbers that are associated with severe DNA damage (Yuan
et al., 2010). No signiﬁcant differences were observed in the
number and distribution of pH2AX-positive cells in the skin in
samples irradiated with red light after mALA application, as
compared with light control samples (Supplementary Figure
S2A online). In sharp contrast, a strong increase in the number
of cells showing pH2AX foci was observed in UV-irradiated
skin (Supplementary Figure S2A online). In the same way, we
found that mALA+Light was unable to induce a noticeable
increase in the number of apoptotic cells in the interfollicular
epithelium or in the HF (Supplementary Figure S2B online).
Finally, we also evaluated whether our protocol could alter
the incidence of skin tumor formation. We performed two
series of experiments involving a single mALA+Light (n=5) or
a dual treatment in a 15-day period (n= 3). In both cases, our
results indicated that the mALA+Light treatment was
completely safe and had no detectable or signiﬁcant capacity
to induce tumors in long-term experiments (up to 18 months).
Switching on in situ ROS production in the skin activates cell
proliferation in epidermal and dermal layers and in the HF stem
cell niche
We next investigated the potential effects of the transient ROS
increase induced by mALA+Light on the function of
epidermal stem cells in the Bg of the HF. To this end, we
ﬁrst proceeded to identify stem cells as label-retaining cells
(LRCs) in pulse and long-chase experiments with the
nucleotide analog 5-bromo-2′-deoxyuridine (BrdU; Braun
et al., 2003). We quantiﬁed the number of LRCs in the Bg
of HFs at 7 weeks after birth, during which time HFs are in a
refractory telogen or resting phase of the growth cycle and are
insensitive to stimulatory signals (Muller-Rover et al., 2001).
We found that the transient in situ ROS production induced
by mALA+Light activated the proliferation of bulge stem cells,
promoting a signiﬁcant increase in the number of BrdU-
labeled cells, which was ﬁrst detected in the skin 2 days after
the treatment (Figure 2a). This was associated with a strong
and parallel increase in the number of dividing (Ki67 positive)
cells in the Bg (Figure 2b), indicating a proliferative response
of the HF stem cell niche. The number of BrdU-labeled cells
reverted to normal levels, as compared with control animals,
6 days after the treatment (Figure 2a), indicating the transient
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Figure 1. Photodynamic treatment with mALA and red light induces a transient production of ROS in the skin. (a) Accumulation of endogenous PpIX after
mALA topic treatment in the back skin. The left side in the same animal was used as control. (b) Left panel: PpIX-dependent ROS (mALA+Light) production
monitored by DHF-DA. Right panel: time-course analysis of relative ROS production in the back skin; the relative integrated density of DHF-DA ﬂuorescent
emission of mALA+Light versus Light regions in each animal was quantiﬁed at different times after irradiation and normalized as described in methodology. The
mean± SE was represented (n= 4 for each time point). (c) Localization of PpIX in the tail skin (ﬂuorescence microscopy images). (d) ROS production in the tail
skin after mALA+Light, as revealed by hET showing an increased and sustained accumulation in the bulge region of the hair follicle. Representative confocal
microscopy images (maximum projections) are shown. Bars= 100 μm. DHF-DA, 2′,7′-dichlorodihydroﬂuorescein diacetate; hET, 2-hydroxyethidium; mALA,
methyl aminolevulinate; PpIX, protoporphyrin IX; ROS, reactive oxygen species.
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nature of the biochemical stimulus. These results were
conﬁrmed using a transgenic murine model in which GFP is
expressed under the control of the keratin1-15 promoter, a
molecular marker of HF epidermal stem cells (Morris et al.,
2004). We found a signiﬁcant increase of GFP-positive cells
in the Bg of the HF 2 days after mALA+Light stimulus that
returned to normal levels 6 days after the treatment
(Supplementary Figure S3 online).
We also observed that mALA+Light promoted a transient
increase in the number of proliferating cells in the epidermal
and dermal layers of the skin starting 2 days after the
treatment and returning to normal levels by day 6 (Figure 2c;
Supplementary Figure S4A online). This proliferative pulse
was associated with a transient epidermal hyperplasia and a
signiﬁcant increase of dermal cellularity 2 days after treatment
that disappeared by day 6 (Figure 2c; Supplementary Figure
S5C online). A strong corniﬁcation was also observed in
treated skin regions (Figure 2c), suggesting an overall
acceleration of tissue turnover rate. These processes were
not associated with histopathological features of inﬂammation
or with the induction of molecular skin inﬂammation markers,
such as myeloperoxidase (MPO) (Figure 2c; Supplementary
Figures S4B and S5C online). As a whole, these results are in
agreement with our previous report in cultured keratinocytes
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Figure 2. Switching on in situ ROS production in the skin activates stem cell proliferation in the hair follicle niche and promotes a transient proliferation of
epidermal and dermal cells. (a) BrdU label-retaining cell (LRC) quantiﬁcation in the hair follicle bulge region. The mean+SE (n= 4) is represented. (b)
Immunological detection of the Ki67 proliferation marker in the hair follicle bulge region. (c) Dorsal skin histological sections stained for inmunohistochemical
detection of Ki67 (left panels) or with Masson’s trichrome (middle panels) showing transient effects in the skin induced by mALA+Light treatments, including cell
proliferation, hyperplasia in the epidermis (vertical bars), a signiﬁcant increase in dermal cellularity (squares), and strong corniﬁcation (arrowheads). Squares
indicate equivalent areas in which cell numbers were quantiﬁed. Right panels show the quantiﬁcation of interfollicular epidermis (IFE) thickness and dermal
cellularity in 10 histological ﬁelds. The mean+SD (n= 3) is represented. In (a) and (b), representative confocal microscopy images (maximum projections) of tail
epidermis whole-mounts are shown. Bars=100 μm. mALA, methyl aminolevulinate; ROS, reactive oxygen species.
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(Blazquez-Castro et al., 2012) and indicate that a transient
production of ROS in the skin promotes a transient
proliferative response in the tissue that can activate the
epidermal stem cell niche.
Switching on in situ ROS production in the skin stimulates hair
growth and accelerates burn healing
We reasoned that the effect of mALA+Light on cell prolifera-
tion in the skin and, particularly, on stem cells contained in
the HF Bg should produce a physiological response in the
target tissue. Supporting this concept, we observed that mALA
+Light strongly promoted hair growth after shaving stimula-
tion during the refractory telogen phase (Figure 3a;
Supplementary Figure S5A online). Importantly, the use of
antioxidant compounds such as ascorbic acid (AA) and
N-acetylcysteine (NAC) abolished the differences in HF
growth rates induced by mALA+Light with respect to Light
control skin (Figure 3a and b; Supplementary Figure S5A
online). In agreement with this observation, antioxidant
treatment signiﬁcantly inhibited the production of ROS
(Figure 3a and c) and the activation of cell proliferation
(Figure 3d) induced by mALA+Light in the tissue. It is to note
that, as we have observed interindividual variations in the
timing of hair growth in a day-range after the shaving
stimulus, the comparisons between treated and control skin
to quantify the mALA-phototreatment (mALA-PT) output were
always established between different skin regions in the
same mouse.
Morphological features and Lef1 expression in the hair
germ indicated that anagen entry occurred about 6 days after
treatments in mALA+Light-treated skin but not in the
correlative light-treated skin controls or in nontreated skin
(normal anagen) showing spontaneous anagen entry
(Figure 3e). As expected, anagen entry was also observed in
Light controls and in nontreated skin about 10 days after
treatments as a consequence of shaving stimulation, showing
Lef1 expression and cell proliferation in the hair germ and
dermal papilla (Figure 3e and f). However, mALA+Light-
treated skin consistently showed larger HFs with extensive
cell proliferation at equivalent time points (Figure 3e and f). As
a whole, these results indicate that a controlled and transient
production of ROS in the skin can bypass the strong inhibitory
signaling that occurs at refractory telogen of the HF cycle,
forcing the premature entry into the anagen growth phase.
These results prompted us to investigate the ability of the
transient ROS production to stimulate the regenerative
potential of the skin. To this end, we performed a series of
burn healing experiments. As shown in Figure 4, mALA+Light
signiﬁcantly accelerated the healing process after 2nd-degree
burn injuries in the skin. Remarkably, this regenerative effect
was associated with extensive cell proliferation in the Bg of
HFs adjacent to the burned area (Figure 4d), indicating the
activation of this stem cell niche. Taken together, these results
suggest that the activation of skin proliferation and of the HF
stem cell niche by a transient ROS production is a molecular
signal able to stimulate different homeostatic programs in the
skin, including hair growth and tissue regeneration.
Switching on in situ ROS production in the skin promotes a
transient activating phosphorylation of cSrc kinase
We next sought to investigate the molecular mechanisms
underlying the stimulation of skin induced by mALA+Light
treatments. Since, as demonstrated above, this stimulation
results in a transient proliferative wave 2 days after the
treatment, returning to normal levels by day 6, we focused
on this time period. We studied signaling pathways that are
known to have key roles in the activation of epidermal stem
cell function and HF growth, including Wnt/β-catenin,
mitogen-activated protein kinases (MAPK), and PI3K/Akt
signaling pathways. Interestingly, no changes in expression
levels of either β-catenin or a metabolically stable, constitu-
tively active form of this protein were detected after mALA
+Light treatment (Figure 5a). Accordingly, no signiﬁcant
changes in the distribution of β-catenin were observed in
mALA+Light-treated skin as compared with control samples, in
both cases showing a major localization at the cell membrane
and no nuclear translocation (Supplementary Figure S6A
online), a key indicator of β-catenin-dependent transcriptional
activation. As described above (Figure 3e) and as expected,
Lef1 expression was found in HFs since day 6, and it was
remarkable on advanced anagen, around 10 days after mALA-
PT. In a similar way, no changes of phosphorylation at critical
Thr/Tyr residues in different MAPK including JNK, p38, and
ERK1/2, which are key indicators of signaling pathway
activation, were observed after mALA+Light (Supplementary
Figure S6B online). By contrast, a signiﬁcant increase in
phosphorylated Akt, similar to the increase observed in a
neurosphere model (Le Belle et al., 2010), and a strong
phosphorylation of Src kinase at Tyr416 were transiently
detected 2 days after mALA+Light (Figure 5a). Interestingly, Src
protein showed an increased accumulation in the epidermis of
mALA+Light skin samples 2 days after treatment (Figure 5b)
that disappeared at day 6 (Figure 5a). These results are
consistent with our previous observations indicating a role for
Src in the ROS-dependent induction of cell proliferation in
human keratinocytes (Blazquez-Castro et al., 2012).
Switching on in situ ROS production in the skin induces a
transient transcriptional activation of prolactin family 2
subfamily c members
To get a deeper insight into the molecular mechanism
underlying the ROS-dependent, Src-driven activation of the
epidermal stem cell niche, we performed a series of large-
scale microarray analyses of mRNA expression, both in back
and tail epidermis after mALA+Light as compared with
control samples (GEO accession number GSE55135). Several
genes showed signiﬁcant transcriptional alterations 2 days
after mALA+Light that were similarly modulated in tail and
back epidermis (Table 1). It is to note that this large-scale
analysis showed that mALA-PT was not associated with
transcriptional proﬁles of inﬂammation or injury response.
The transcriptional proﬁles of genes of interest were validated
in all cases by quantitative real-time reverse-transcriptase–
PCR in dorsal skin at both 2 or 6 days after mALA+Light
(Figure 5c), revealing that the majority of genes transcription-
ally altered at 2 days returned to normal expression levels
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6 days after the treatment. In agreement with our previous
observations, targets of Wnt/β-catenin signaling in the skin,
such as Jag1, Ovol1, and Axin2, were transcriptionally
repressed 2 days after mALA+Light (Figure 5c). Interestingly,
the strongest transient transcriptional activation induced by
mALA+Light was observed for members of the prolactin
family 2 subfamily c of growth factors. In particular, Prl2c3,
also known as proliferin-2, showed a marked transient
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Figure 3. Switching on in situ ROS production in the skin stimulates hair growth. (a) Top row: Induction of hair growth during the refractory telogen phase by
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activation 2 days after switching on ROS production by mALA
+Light (Table 1; Figure 5c). More surprisingly, we found a
signiﬁcantly increased expression of Prl2c3 protein in the skin
associated with a strong nuclear localization in the hyper-
plastic interfollicular epidermis (Figure 5d).
DISCUSSION
Here we have shown that switching on in situ ROS production
can regulate functional responses in a tissue through the
stimulation of cell proliferation and of a stem cell niche. Our
results are in agreement with recent reports showing a role for
ROS during the stimulation of neural stem cells in vitro in a
neurosphere model (Le Belle et al., 2010) and in the
deregulation of intestinal stem cell proliferation that occurs
during colorectal cancer initiation (Myant et al., 2013). In
these studies, an exogenous and/or continuous ROS supply or
a systemic ROS depletion is used to evaluate a speciﬁc effect
on a tissue or in biological systems. As a complement to these
studies, our experimental approach implies a local and
transient activation of in situ ROS production using the
molecular machinery of the tissue. In this sense, our results
are in close consonance with the observation that a transient
ROS production occurs during tail regeneration in Xenopus
tadpoles (Love et al., 2013). In this report, it is shown that
activation of a regenerative signal, i.e., cutting the tadpole, is
accompanied by a transient production of ROS. Here we
demonstrate that switching on in situ transient ROS
production activates a regenerative signal. It has also been
reported that the mitochondrial transcription factor A (TFAM)
is required for normal HF development and in vitro
keratinocyte differentiation (Hamanaka et al., 2013),
suggesting indirectly that mitochondrial ROS can have an
important role in the regulation of skin function. Here we
directly demonstrate that a transient generation of ROS in the
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mouse skin activates the HF stem cell population, promoting
hair growth in the refractory telogen phase and accelerating
burn healing. In this context, it would be interesting to
evaluate the clinical potential of a transient ROS production
in situ in the skin to stimulate tissue homeostasis—e.g., to
improve the healing process of small burns and chronic
wounds or to activate hair growth or prevent hair loss in
certain types of alopecia.
We have found that switching on in situ ROS production
by mALA-PT promotes a transient proliferative pulse in the
tissue, including bulge cells, 2 days after the treatment. This
proliferative burst results in extensive anagen development of
HFs by days 8–10, showing extensive cell proliferation and
Lef1 expression particularly in the hair germ, and subsequent
hair growth by days 12–19 after mALA-PT. At day 2, most HFs
are in telogen and, consequently, no evidence of β-catenin
accumulation or transcriptional activation of Wnt/β-catenin
signaling is observed. However, a signiﬁcant activating
phosphorylation of cSrc occurs at this time point. This result
is particularly interesting, as no signiﬁcant roles are usually
assigned to Src kinase in relation to the regulation of skin stem
cell function and/or the HF growth cycle. However, it has
been reported that Src protein expression and activity are
regulated during normal HF cycle (Serrels et al., 2009). In the
same context, the molecular mechanisms regulating Src
kinase activity by ROS in cultured cells are well
characterized (Giannoni et al., 2010). These observations
suggest that Src activity, independently or in combination
with a controlled ROS production, can be an important
partner in the skin signaling network, which merits further
investigation. In this context, we hypothesize that mALA-PT
induces, 2 days after treatment, an initial, cSrc-dependent,
proliferative wave in the skin that is able to activate HF stem
cell niches. This activation results in standard, Lef1-depen-
dent, anagen entry around 6 days after treatments.
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We have further shown that transiently switching on ROS
production in the skin promotes a strong and unexpected
transcriptional activation of prolactin family 2 subfamily c gene
members, particularly Prl2c3. Surprisingly, we found that
Prl2c3 was signiﬁcantly translocated to the nucleus in most
cell layers in the hyperplastic epithelium after mALA+Light
treatment, suggesting that this hormone-like protein can have
nuclear functions. Interestingly, it has been reported that this
mitogen is expressed in the HF anagen growth phase (Fassett
and Nilsen-Hamilton, 2001), and it facilitates the expansion of
hematopoietic stem cells ex vivo (Choong et al., 2003). The
role of Prlc3 in the skin is currently under investigation. In this
context, the procedure presented here to transiently activate
endogenous ROS production in the skin has been proven to be
an efﬁcient tool not only to suggest a physiological role for ROS
in vivo but also to identify new signaling pathways and factors
potentially implicated in the regulation of skin homeostasis.
MATERIALS AND METHODS
Animals
Seven-week-old C57BL/6 mice, including the strain B6.Cg-Tg(Krt1-
15-EGFP)2Cot/J (Morris et al., 2004), were used. When possible,
littermates were included in each experiment and comparisons
were made between animals of the same sex. Both male and
female mice were used in experiments using tail skin. Only female
mice were used in experiments performed in the back skin. All
animal husbandry and experimental procedures were conducted in
compliance with 2010/63/UE European guideline or approved by the
Table 1. Genes signiﬁcantly up- or downregulated 2 days after mALA-PT in both back and tail epidermis
Gene Access no. GenBank Expression ratio Associated functions
Prl2c3 NM_011118 (+) 144.93 Hormone-like growth factor. Putative role in wound healing and hair follicle cycle.
S100a8 NM_013650 (+) 25.55 Calcium- and zinc-binding protein, which has a wide plethora of intracellular and extracellular
functions, including the modulation of the NADPH-oxidase activity and a role as an oxidant
scavenger, respectively.
Gsta4 NM_010357 (+) 21.24 Conjugation of reduced glutathione to a wide number of exogenous and endogenous
hydrophobic electrophiles.
Hip1 NM_146001 (+) 16.78 Plays a role in clathrin-mediated endocytosis and trafﬁcking. Proapoptotic protein. May be
required for differentiation, proliferation, and/or survival of somatic and germline progenitors.
Sox5 NM_011444 (+) 11.73 TF that has a role in cell lineage establishment during the development.
Fgf7 (Kgf) NM_008008 (+) 4.40 Growth factor active on keratinocytes. Important role in the regulation of cell proliferation and
differentiation.
Lef1 NM_010703 (+) 3.81 Participates in the Wnt signaling pathway. May have a role in hair cell differentiation and
follicle morphogenesis.
Lrp1 NM_008512 (+) 3.15 Endocytic receptor involved in endocytosis and in the phagocytosis of apoptotic cells. May
modulate cellular events, such as kinase-dependent intracellular signaling.
Tln2 NM_001081242 (+) 3.11 Major component of focal adhesion plaques that links integrin to the actin cytoskeleton.
Gapdh NM_008084 (+) 3.07 Has both glyceraldehyde-3-phosphate dehydrogenase and nitrosylase activities, thereby
playing a role in glycolysis and nuclear functions, respectively.
Myh4 NM_010855 (+) 2.79 Muscle contraction.
Fgf18 NM_008005 (+) 2.38 Important role in the regulation of cell proliferation, cell differentiation and cell migration.
Stimulates hepatic and intestinal proliferation.
Cdh11 NM_009866 (− ) 2.62 Calcium-dependent cell adhesion protein (homophilic interactions).
Bmp2 NM_007553 (− ) 3.14 Induces cartilage and bone formation.
Notch2 NM_010928 (− ) 3.14 Functions as a receptor for membrane-bound ligands Jagged1, Jagged2, and Delta1 to regulate
cell-fate determination.
Rora NM_013646 (− ) 3.16 Orphan nuclear receptor. Regulates a number of genes involved in lipid metabolism, in
cerebellum, and photoreceptor development in circadian rhythm and skeletal muscle
development.
Myc NM_010849 (− ) 3.31 TF involved in the regulation of cell proliferation and cell differentiation of stem cells.
Mest NM_008590 (− ) 4.31 Belongs to the AB hydrolase superfamily. Expressed in the mesodermal tissues.
Pcaf AF254442 (− ) 4.35 Functions as a histone acetyltransferase (HAT) to promote transcriptional activation.
Ikzf4 NM_011772 (− ) 5.03 DNA-binding protein that binds to the 5′-GGGAATRCC-3′ Ikaros-binding sequence. Interacts
with SPI1 and MITF.
Abbreviation: mALA, methyl aminolevulinate; MITF, microphthalmia-associated transcription factor; TF, transcription factor.
The expression ratios obtained by microarray analysis are referred to fold changes of mRNA expression in mALA+Light as compared with control samples.
Associated functions were extracted from UniProt KB.
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Subcommittee on Research Animal Care (IACUC) of Massachusetts
General Hospital (Boston, MA), in accordance with the guidelines of
the National Institutes of Health (NIH).
Identiﬁcation of LRCs in tail skin epithelium
Long-term BrdU (Sigma-Aldrich, St. Louis, MO) LRCs were generated
and characterized as previously described (Braun et al., 2003).
Brieﬂy, 10-day-old mice were injected intraperitoneally once a day
during four consecutive days with 50mg per kg body weight BrdU
dissolved in phosphate-buffered saline (PBS). After the labeling
phase, mice were allowed to grow until the age of 7 weeks before
any treatment. To prepare wholemounts of the tail epidermis, tails
were clipped, skin was peeled from tails and incubated in 5mM
EDTA in PBS for 4 hours at 37 °C. Intact sheets of the epidermis were
separated from the dermis using forceps and ﬁxed in 4%
formaldehyde in PBS.
Burning procedure
For induction of burn injuries, mice were anesthetized and shaved. A
brass bar (1 cm in cross-section) that was preheated (~95 °C) by
immersing in boiling water was applied on the dorsal surface of each
mouse and maintained in contact with the skin for 5 seconds. The
resulting nonlethal, partial-thickness, 2nd-degree burns measured
~1.3× 1.3 cm. For the analysis of proliferating cells around the
wound, animals received 2 sequential intraperitoneal injections of
50mg per kg body weight BrdU every 12 hours, starting 4 hours after
mALA-PT.
Photodynamic treatments
All experiments were performed during the refractory telogen phase
of the HF growth cycle (7-week-old mice). For photodynamic
treatments, mALA as topical cream (Metvix, Galderma, Lausanne,
Switzerland) was used. For tail skin experiments, Metvix was applied
directly on the skin. For back skin treatments, animals were
completely shaved with a hair clipper and depilatory cream (Veet,
Hull, UK) and washed with PBS. We applied 25mg of Metvix
covering the area of interest. After 2.5 hours of incubation in
darkness, animals were anesthetized and the accumulation of PpIX
was evaluated in situ by measuring the characteristic red ﬂuores-
cence under 407-nm blue-light excitation. To conduct the photo-
dynamic treatments (mALA+Light), a red-light (636 nm) emission was
subsequently applied on the dorsal surface of the tissue to a total
dose of 2.5–10 J cm−2, using a LED lamp (Aktilite, Photocure ASA,
Oslo, Norway). Light control animals received only red light,
whereas Dark control animals received only mALA and they were
kept in the dark for at least 48 hours after the treatment. For inhibitory
experiments using AA (from Sigma, St. Louis, MO), two doses of
100mg/ml AA in 50% ethanol spaced 30 minutes were topically
applied on the skin between the application of mALA and red-light
irradiation. For the alternative experiments using NAC (from Sigma),
a solution containing 20mgml− 1 NAC in PBS was intraperitoneally
inoculated daily during 5 days at a dose of 100mg per kg body
weight, until the day that mALA-PT was applied. Photodynamic
treatments on burned skin were performed 24 hours after the burning
procedure. In all cases, the percent of animals showing hair growth
acceleration in treated back skin regions as compared with control
regions in the same animal was evaluated. An animal showing hair
growth acceleration was deﬁned as an animal showing full hair
growth all along the treated region, typically by days 12–19 after
shaving, but only limited or no hair growth in the control region.
Monitoring ROS production
ROS production in tail skin was evaluated ex vivo using hydro-
ethidine (Sigma-Aldrich), which reacts with ROS to produce
ﬂuorescent dye 2-hydroxyethidium. Samples were incubated at
37 °C for 3 hours in a solution with 5mM EDTA in PBS, containing
2mM mALA in the case of treated samples. Hydroethidine was added
to a ﬁnal concentration of 3.2 μM. After 1 hour, the skin was irradiated
with 10 J cm−2 of 636-nm light and ﬁxed.
For in vivo detection of ROS produced in back skin during
photodynamic treatment, the ROS-sensitive 2′,7′-dichlorodihydro-
ﬂuorescein diacetate (DHF-DA; Sigma-Aldrich) was used. To assess
the inhibitory effect of AA, two independent groups of animals were
established for each time point for normalizing the obtained signal
(mALA+Light/Light) with respect to AA animals. After dorsal skin
shaving and PT treatment application, as previously described
(Metvix 2.5 hours in dark followed by the irradiation with 2.5 J cm− 2
of 636 nm light), 1 mgml− 1 DHF-DA in 50% ethanol was topically
applied on the tissue at different time points after the irradiation (5,
20, and 100 minutes). ROS levels generated in the skin were
determined 45minutes after the application of DHF-DA in all cases,
using an IVIS Lumina 2 imaging system (Xenogen, Alameda, CA), by
measuring the ﬂuorescent signal emitted by the ﬂuorescein produced
through the oxidation of DHF-DA. The ﬁlter settings were 445–
490 nm for the excitation and 515–575 nm for the emission.
Immunological and histological methods
Primary antibodies used were FITC-conjugated mouse monoclonal
anti BrdU (Roche, Madrid, Spain); rabbit monoclonal antibodies
against Src, Phospho-Src (Tyr416), AKT, Phospho-AKT (Ser473), p38
MAPK, Phospho-p38 MAPK (Thr180/Tyr182), p44/42 MAPK, Phos-
pho-p44/42 MAPK (Thr202/Tyr204), Phospho SAPK/JNK (Thr183/
Tyr185), and gammaH2AX (Ser 139) and Lef1 (all from Cell Signaling
Technologies, Leiden, The Netherlands); rabbit monoclonal anti Ki67
(Neo Markers, Fremont, CA); rabbit polyclonal anti Src (Abcam,
Cambridge, UK); mouse monoclonal anti β-catenin (BD, Franklin
Lakes, NJ); mouse monoclonal anti Active-β-catenin (Millipore,
Billerica, MA); goat polyclonal anti-Proliferin 2 (Prl2c3) and anti-
MPO (both from Santa Cruz Biotechnology, Dallas, TX); and mouse
monoclonal antibodies against PCNA (Calbiochem, Billerica, MA),
tubulin, and BrdU (both from Sigma).
For BrdU-FITC immunostaining in tail skin epithelium whole-
mounts, ﬁxed epidermal pieces were sequentially treated with 1 N
HCl for 45 minutes at 37 °C and Tris-borate-EDTA for 5 minutes at
room temperature and washed abundantly with distilled water.
Permeabilization and blocking were carried out by incubation with
PTG buffer (PBS containing 0.5% Triton X-100 and 0.2% gelatin) for
30 minutes at room temperature. Next, the samples were incubated
with the FITC-conjugated primary antibody against BrdU (Roche)
diluted 1:50 in PBS, overnight at 37 °C. For ﬂuorescence immunos-
taining of pH2AX, positive control samples were obtained from
animals exposed to a total dose of 7.44 J cm− 2 of UVB light, using a
lamp with a 312-nm emission peak (Philips TL, Eindhoven,
The Netherlands, UV). Apoptosis was detected in whole-mounts
using the TUNEL detection kit (Roche) according to the instructions
of the manufacturer. Images were obtained in Leica TCS SP2 AOBS
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spectral confocal microscope and processed using the FIJI software
(Image J 1.49 National Institutes of Health, Bethesda, MD).
For immunohistochemical staining, hydrated parafﬁn samples
were treated with trypsin (Thermo Scientiﬁc, Waltham, MA) for 30
minutes at 37 °C before incubating overnight with primary anti-
bodies, and it was revealed using the Envision Flex/HRP (Dako,
Barcelona, Spain) secondary antibodies cocktail and DAB kit (Vector
Laboratories, Peterborough, UK).
For immunobloting, skin samples were homogenized at 4 °C in
cold NT lysis buffer (50 mM Tris-HCl, pH 7.4, 100mM NaCl, 5 mM
MgCl2, 5 mM CaCl2, 1% NP-40, 1% Triton X-100, 2 mM phenyl-
methyl-sulfonyl ﬂuoride, 20 μg/ml aprotinin, and 1mM sodium
orthovanadate).
RNA extraction and gene expression analysis
RNA was isolated from back skin and back and tail epidermis with
TriPure Isolation Reagent (Roche) and the RNeasy Mini kit (Qiagen,
Barcelona, Spain). Gene expression signatures were characterized
using standardized mouse global mRNA expression arrays (Agilent
Technologies, Santa Clara, CA; Agilent.SingleColor.14868). Gene
expression analysis included pooled samples (n= 3) obtained 2 days
after the treatment. Pools prepared from both back and tail epidermis
were independently analyzed. Large-scale gene expression results
were validated by quantitative real-time reverse-transcriptase–PCR in
back skin samples. Primer sequences are available upon request.
Statistical analysis
Quantiﬁcations of LRC and Krt1-15-GFP expression in the Bg were
performed on confocal images (30 HFs/animal, 3 animals/group).
BrdU-positive cells were quantiﬁed in the three HFs closest to the
burned area in 3 different animals per condition. Comparisons
between groups were performed by Student’s t-test using the SPSS
15.0 software (IBM, Spain). Skin thickness was measured in 10
different regions of the interfollicular epidermis per mouse including
3 animals per condition.
In vivo ROS production detected with the IVIS Lumina 2 was
quantiﬁed using the FIJI software. The relative DHF-DA Integrated
density was calculated for each mouse as the ratio of the integrated
density obtained in mALA-treated skin relative to Light control area.
For statistical comparison, the integrated density was normalized by
calculating the ratio (vehicle/AA) for all possible pairs between AA
and vehicle-treated animals for each time point. The average and
standard error (SE) were represented and means of different time
points were compared using analysis of variance.
For statistical analyses of gene expression data, an unpaired t-test
was applied, setting P≤ 0.05 and fold change ≥ 2.0 as limits for
signiﬁcance. Quantitative real-time reverse-transcriptase–PCR data
were analyzed using a comparative CT method, by using 18S
ribosomal RNA expression as an internal control. Gene expression
fold changes were represented as the ratio between means of 2−ΔCt
values of mALA+Light and Light control groups mean values.
Differentially expressed genes were selected on the basis of the
Student’s t-test comparison of means of 2−ΔCt values between both
groups.
For quantiﬁcation of burn assays, day-to-day digital images were
analyzed. The unhealed area was quantiﬁed using the FIJI software.
The area under the curve was calculated separately for each mouse,
and means were compared by the Student’s t-test.
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